A single point mutation in the Plasmodium falciparum FtsH1 metalloprotease confers actinonin resistance

ELife
Christopher Dean GoodmanG. I. McFadden

Abstract

The antibiotic actinonin kills malaria parasites (Plasmodium falciparum) by interfering with apicoplast function. Early evidence suggested that actinonin inhibited prokaryote-like post-translational modification in the apicoplast; mimicking its activity against bacteria. However, Amberg Johnson et al. (2017) identified the metalloprotease TgFtsH1 as the target of actinonin in the related parasite Toxoplasma gondii and implicated P. falciparum FtsH1 as a likely target in malaria parasites. The authors were not, however, able to recover actinonin resistant malaria parasites, leaving the specific target of actinonin uncertain. We generated actinonin resistant P. falciparum by in vitro selection and identified a specific sequence change in PfFtsH1 associated with resistance. Introduction of this point mutation using CRISPr-Cas9 allelic replacement was sufficient to confer actinonin resistance in P. falciparum. Our data unequivocally identify PfFtsH1 as the target of actinonin and suggests that actinonin should not be included in the highly valuable collection of 'irresistible' drugs for combatting malaria.

References

Aug 20, 1976·Science·W Trager, J B Jensen
Jun 8, 2001·Trends in Parasitology·J WiesnerH Jomaa
Dec 19, 2001·Archives of Biochemistry and Biophysics·V Bracchi-RicardD Pei
Aug 18, 1962·Nature·J J GORDONG A MILLER
Feb 10, 2007·Molecular and Biochemical Parasitology·Christopher Dean GoodmanGeoffrey I McFadden
Jun 2, 2014·Nature Biotechnology·Mehdi GhorbalJose-Juan Lopez-Rubio
Jan 10, 2017·Cellular Microbiology·Natalie J SpillmanDaniel E Goldberg
Nov 8, 2017·Antimicrobial Agents and Chemotherapy·Taher UddinChristopher Dean Goodman

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection

Software Mentioned

Geneious Prime
Sequencher

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.